Stock TBIO TRANSLATE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Translate Bio, Inc.

Equities

TBIO

US89374L1044

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
TRANSLATE BIO : Roth Capital Adjusts Translate Bio's Price Target to $38 from $45, Keeps Neutral Rating
MT
TRANSLATE BIO : SVB Leerink Adjusts Translate Bio's Price Target to $38 from $19, Keeps Market Perform Rating
MT
TRANSLATE BIO : Jefferies Downgrades Translate Bio to Hold from Buy
MT
TRANSLATE BIO : William Blair Downgrades Translate Bio to Market Perform From Outperform
MT
TRANSLATE BIO : SVB Leerink Downgrades Translate Bio to Market Perform From Outperform, Adjusts PT to $18 From $21
MT
TRANSLATE BIO : Jefferies Adjusts Translate Bio's Price Target to $25 from $28, Keeps Buy Rating
MT
TRANSLATE BIO : Goldman Sachs Adjusts Translate Bio's Price Target to $26 from $31, Keeps Buy Rating
MT
TRANSLATE BIO : Roth Capital Adjusts Translate Bio's Price Target to $28 from $37, Keeps Buy Rating
MT
TRANSLATE BIO : SVB Leerink Adjusts Translate Bio's Price Target to $21 From $33, Keeps Outperform Rating
MT
TRANSLATE BIO : HC Wainwright Adjusts Translate Bio's Price Target to $28 From $32, Maintains Buy Rating
MT
TRANSLATE BIO : Evercore ISI Downgrades Translate Bio to In-Line From Outperform; Price Target is $21
MT
TRANSLATE BIO : Truist Securities Downgrades Translate Bio to Hold From Buy, Adjusts Price Target to $20 From $40
MT
TRANSLATE BIO : Roth Capital Adjusts Translate Bio's Price Target to $37 From $30, Maintains Buy Rating
MT
TRANSLATE BIO : SVB Leerink Adjusts Translate Bio PT to $34 From $30, Maintains Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Translate Bio, Inc.
  5. Analyst Reco.